2-Methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 97%, 100mg

3,5-Dibromo-2-hydroxy-N-(4-methoxy-phenyl)-benzamide, 95.0%, 1g

1-(4-tert-Butylphenyl)-2-chloroethanone, 97.0%, 5g

7-BROMO-4-CHLORO-1H-IMIDAZO[4,5-C]PYRIDINE, 95.0%, 10g

tert-Butyl 5-methyl-2,4-dioxopiperidine-1-carboxylate, 95.0%, 250mg

2-(chloromethyl)-5-ethyl-1,3,4-oxadiazole, 1g

1-Methyl-1H-pyrazol-4-ylamine, 99.00%, 1g

Hidrato de ácido molibdofosfórico, mínimo 99 %, pa, ACS, 100 g, envase de plástico.

3-(chloromethyl)-5-cyclopropyl-1,2,4-oxadiazole, 95.0%, 10g

1-TERT-BUTYL 3-ETHYL 5-HYDROXYPIPERIDINE-1,3-DICARBOXYLATE, 95.0%, 250mg

1,4-Dioxaspiro[4.5]decan-8-ylhydrazine dihydrochloride, 98%, 100mg

Nanopolvo de óxido de cobalto(II,III) 99,8% APS 20-30 nm 25 g

(4-Bromo-6-methylpyridin-2-yl)methanol, 95.0%, 5g